184 related articles for article (PubMed ID: 34277403)
1. Enzalutamide-Induced Upregulation of PCAT6 Promotes Prostate Cancer Neuroendocrine Differentiation by Regulating miR-326/HNRNPA2B1 Axis.
Liu B; Jiang HY; Yuan T; Luo J; Zhou WD; Jiang QQ; Wu D
Front Oncol; 2021; 11():650054. PubMed ID: 34277403
[TBL] [Abstract][Full Text] [Related]
2. Long Non-coding RNA AFAP1-AS1 Facilitates Prostate Cancer Progression by Regulating miR-15b/IGF1R Axis.
Liu B; Jiang HY; Yuan T; Zhou WD; Xiang ZD; Jiang QQ; Wu DL
Curr Pharm Des; 2021; 27(41):4261-4269. PubMed ID: 34126893
[TBL] [Abstract][Full Text] [Related]
3. lncRNA PCAT6 facilitates cell proliferation and invasion via regulating the miR-326/hnRNPA2B1 axis in liver cancer.
Luo J; Zheng J; Hao W; Zeng H; Zhang Z; Shao G
Oncol Lett; 2021 Jun; 21(6):471. PubMed ID: 33907581
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-147b induces neuroendocrine differentiation of prostate cancer cells by targeting ribosomal protein RPS15A.
Natani S; Ramakrishna M; Nallavolu T; Ummanni R
Prostate; 2023 Jul; 83(10):936-949. PubMed ID: 37069746
[TBL] [Abstract][Full Text] [Related]
5. m
Lang C; Yin C; Lin K; Li Y; Yang Q; Wu Z; Du H; Ren D; Dai Y; Peng X
Clin Transl Med; 2021 Jun; 11(6):e426. PubMed ID: 34185427
[TBL] [Abstract][Full Text] [Related]
6. LncRNA PCAT6 Accelerates the Progression and Chemoresistance of Cervical Cancer Through Up-Regulating ZEB1 by Sponging miR-543.
Ma Z; Gu G; Pan W; Chen X
Onco Targets Ther; 2020; 13():1159-1170. PubMed ID: 32103984
[TBL] [Abstract][Full Text] [Related]
7. Sevoflurane Inhibits Proliferation, Invasion, but Enhances Apoptosis of Lung Cancer Cells by Wnt/β-catenin Signaling via Regulating lncRNA PCAT6/miR-326 Axis.
Su G; Yan Z; Deng M
Open Life Sci; 2020; 15():159-172. PubMed ID: 33987473
[TBL] [Abstract][Full Text] [Related]
8. The lncRNA TPT1-AS1 promotes the survival of neuroendocrine prostate cancer cells by facilitating autophagy.
Chen PA; Chang PC; Yeh WW; Hu TY; Hong YC; Wang YC; Huang WJ; Lin TP
Am J Cancer Res; 2024; 14(5):2103-2123. PubMed ID: 38859837
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of lncRNA
Shi R; Wu P; Liu M; Chen B; Cong L
Onco Targets Ther; 2020; 13():3025-3037. PubMed ID: 32308433
[TBL] [Abstract][Full Text] [Related]
10. Long Non-Coding RNA PCAT6 Induces M2 Polarization of Macrophages in Cholangiocarcinoma
Tu J; Wu F; Chen L; Zheng L; Yang Y; Ying X; Song J; Chen C; Hu X; Zhao Z; Ji J
Front Oncol; 2020; 10():605877. PubMed ID: 33552977
[TBL] [Abstract][Full Text] [Related]
11. miR-145-5p Inhibits Neuroendocrine Differentiation and Tumor Growth by Regulating the SOX11/MYCN Axis in Prostate cancer.
Ji S; Shi Y; Yang L; Zhang F; Li Y; Xu F
Front Genet; 2022; 13():790621. PubMed ID: 35368699
[TBL] [Abstract][Full Text] [Related]
12. Tumor protein D52 (isoform 3) induces NF-κB - STAT3 mediated EMT driving neuroendocrine differentiation of prostate cancer cells.
Sruthi KK; Natani S; Ummanni R
Int J Biochem Cell Biol; 2024 Jan; 166():106493. PubMed ID: 37935328
[TBL] [Abstract][Full Text] [Related]
13. AMPK/SIRT1 signaling through p38MAPK mediates Interleukin-6 induced neuroendocrine differentiation of LNCaP prostate cancer cells.
Natani S; Dhople VM; Parveen A; Sruthi KK; Khilar P; Bhukya S; Ummanni R
Biochim Biophys Acta Mol Cell Res; 2021 Sep; 1868(10):119085. PubMed ID: 34171447
[TBL] [Abstract][Full Text] [Related]
14. REST-repressed lncRNA LINC01801 induces neuroendocrine differentiation in prostate cancer via transcriptional activation of autophagy.
Chang CH; Cheng TY; Yeh WW; Luo YL; Campbell M; Kuo TC; Shen TW; Hong YC; Tsai CH; Peng YC; Pan CC; Yang MH; Shih JC; Kung HJ; Huang WJ; Chang PC; Lin TP
Am J Cancer Res; 2023; 13(9):3983-4002. PubMed ID: 37818052
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA PCAT6 regulates bladder cancer progression via the microRNA-143-3p/PDIA6 axis.
Zhang Y; Chen L; Luo G
Exp Ther Med; 2021 Sep; 22(3):947. PubMed ID: 34335889
[TBL] [Abstract][Full Text] [Related]
16. LncRNA PCAT6 promotes tumor progression in osteosarcoma via activation of TGF-β pathway by sponging miR-185-5p.
Zhu C; Huang L; Xu F; Li P; Li P; Hu F
Biochem Biophys Res Commun; 2020 Jan; 521(2):463-470. PubMed ID: 31676070
[TBL] [Abstract][Full Text] [Related]
17. Enzalutamide-resistant related lncRNA NONHSAT210528 promotes the proliferation and invasion of prostate cancer.
Ye C; Chen YG; Qin SF; Tang SY; Li S; Shi MF; Zhou T
Transl Androl Urol; 2022 May; 11(5):643-658. PubMed ID: 35693714
[TBL] [Abstract][Full Text] [Related]
18. Activation of TGF-β - SMAD2 signaling by IL-6 drives neuroendocrine differentiation of prostate cancer through p38MAPK.
Natani S; Sruthi KK; Asha SM; Khilar P; Lakshmi PSV; Ummanni R
Cell Signal; 2022 Mar; 91():110240. PubMed ID: 34986386
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA PCAT6 targets miR-204 to modulate the chemoresistance of colorectal cancer cells to 5-fluorouracil-based treatment through HMGA2 signaling.
Wu H; Zou Q; He H; Liang Y; Lei M; Zhou Q; Fan D; Shen L
Cancer Med; 2019 May; 8(5):2484-2495. PubMed ID: 30938104
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA PCAT6 functions as an oncogene by binding to EZH2 and suppressing LATS2 in non-small-cell lung cancer.
Shi X; Liu Z; Liu Z; Feng X; Hua F; Hu X; Wang B; Lu K; Nie F
EBioMedicine; 2018 Nov; 37():177-187. PubMed ID: 30314898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
